Systemic anti-TNFalpha treatment restores diabetes-impaired skin repair in ob/ob mice by inactivation of macrophages.
about
Exercise, Obesity, and Cutaneous Wound Healing: Evidence from Rodent and Human StudiesAnti-Inflammatory Effects of Rosiglitazone in Obesity-Impaired Wound Healing Depend on Adipocyte DifferentiationEffect of isolated hyperglycemia on native mechanical and biologic shoulder joint properties in a rat modelTNF-alpha is required for the attraction of mesenchymal precursors to white adipose tissue in Ob/ob mice.Heme oxygenase-1 accelerates cutaneous wound healing in mice.Macrophage dysfunction impairs resolution of inflammation in the wounds of diabetic miceThe functional behavior of a macrophage/fibroblast co-culture model derived from normal and diabetic mice with a marine gelatin-oxidized alginate hydrogelWound administration of M2-polarized macrophages does not improve murine cutaneous healing responses.Decrease in neuroimmune activation by HSV-mediated gene transfer of TNFα soluble receptor alleviates pain in rats with diabetic neuropathy.Wound healing in mice with high-fat diet- or ob gene-induced diabetes-obesity syndromes: a comparative study.Complement deficiency promotes cutaneous wound healing in mice.MiRNA in innate immune responses: novel players in wound inflammation.FOXO1 differentially regulates both normal and diabetic wound healing.miRNA in wound inflammation and angiogenesisTumors Alter Inflammation and Impair Dermal Wound Healing in Female Mice.Targeting CD64 mediates elimination of M1 but not M2 macrophages in vitro and in cutaneous inflammation in mice and patient biopsies.Blocking interleukin-1β induces a healing-associated wound macrophage phenotype and improves healing in type 2 diabetesThe role of androgen and androgen receptor in skin-related disorders.Models for diabetic wound healing and healing into percutaneous devices.HOXA3 modulates injury-induced mobilization and recruitment of bone marrow-derived cells.MicroRNA-126 overexpression rescues diabetes-induced impairment in efferocytosis of apoptotic cardiomyocytes.Diabetic Wounds Exhibit Decreased Ym1 and Arginase Expression with Increased Expression of IL-17 and IL-20.Hyperglycaemia inhibits REG3A expression to exacerbate TLR3-mediated skin inflammation in diabetes.Inflammation as a Therapeutic Target for Diabetic Neuropathies.Skin wound healing modulation by macrophages.Phenotypic transitions of macrophages orchestrate tissue repair.Activation of α7nAChR Promotes Diabetic Wound Healing by Suppressing AGE-Induced TNF-α Production.Macrophage-based therapeutic strategies in regenerative medicine.Macrophage Phenotypes Regulate Scar Formation and Chronic Wound Healing.A transgenic mouse model of inducible macrophage depletion: effects of diphtheria toxin-driven lysozyme M-specific cell lineage ablation on wound inflammatory, angiogenic, and contractive processes.Gene expression dynamics during diabetic periodontitis.Substance P promotes wound healing in diabetes by modulating inflammation and macrophage phenotype.Impaired wound healing in mouse models of diabetes is mediated by TNF-alpha dysregulation and associated with enhanced activation of forkhead box O1 (FOXO1).PKCζ as a promising therapeutic target for TNFα-induced inflammatory disorders in chronic cutaneous woundsHigh-mobility group box 1 inhibits gastric ulcer healing through Toll-like receptor 4 and receptor for advanced glycation end products.Macrophage activation dysfunction in impaired wound healing: a potential therapeutic target.Anti-Inflammatory and Skin Barrier Repair Effects of Topical Application of Some Plant Oils.Statin Therapy Negatively Impacts Skeletal Muscle Regeneration and Cutaneous Wound Repair in Type 1 Diabetic Mice.Immuno-modulatory effect of local rhEGF treatment during tissue repair in diabetic ulcers.The influence of titanium surface characteristics on macrophage phenotype polarization during osseous healing in type I diabetic rats: a pilot study.
P2860
Q27023653-759F9DDA-C50C-43AA-8069-5A36008AA0D4Q28354076-78D8B2AA-EDF7-4312-B80B-7FAF87E8817FQ28392350-F7CA87B9-E02E-40CA-A7DD-883C0A2D2F74Q33408808-284BC2BE-1419-4B34-8744-B88F1E1EDA77Q33460409-81B37D65-BE60-41CC-BA51-559FB47A4F7BQ33537990-437DDFB9-1C99-4400-AEF8-6FD54DBBD73FQ33875878-5AFCC78E-44AD-4E00-A807-486C6CF089E5Q33961310-2E9A6438-73D1-490A-B931-72BA72ECE392Q34204658-3ADE7145-CF71-43C0-955B-6C36F962FE19Q34557259-3B5CC6D5-DA95-434F-8E9C-4CB0F9C2D891Q34980307-22978EAD-32DE-44E2-8969-3107EEB25443Q35033664-0EE2E8AE-F646-4A99-A0EB-8BBCAA170E4CQ35543164-9C6FCA1D-08B5-4E59-8E2E-CF37B35071C0Q36102225-64C01321-DF57-432A-A9AF-A71F6E08FAAAQ36109235-2433CC8D-B8C0-4714-98C7-BE0B3B2D5665Q36212734-F238A711-1F4F-4224-AF5E-7377B5A65C5BQ37014908-E24D1E3A-307B-46FC-BB07-626A0C3178E8Q37149457-15950D97-AAFF-4468-B9AA-41D30DC9E151Q37222821-C98BCC17-CA51-42C7-96AE-657373CE17E5Q37322691-BBF73C1D-BA98-4406-8C95-8C37411CF5F3Q37403068-6EFAC859-7069-475F-B099-01070E484FCFQ37408988-94AF0E43-735A-42E7-8202-8430705B6C0EQ37414444-9440C65E-3AAD-4CD8-85C2-EED252DB2CE2Q37450547-EBCBB35D-B8DD-4DF9-A1ED-013C2C77F400Q37787051-D05EEECF-FA7D-4C75-8B28-21153EC3CE60Q38148921-22EC39E8-5B00-4511-A092-93A7171B3AE3Q38813166-AB837CE2-456A-45F6-9EF9-D82E12D874F8Q39319066-50E6CA93-0BB2-478B-BB76-B9A30C93A796Q39438826-1C2B8456-2F52-4663-9C64-BF30A19C61E9Q39837612-6FA308B1-FAB4-4C87-AE47-E657345DB353Q41159150-AE92639D-0DD3-4E8B-A530-D76EF6E8C264Q41464720-F66FC720-B351-4CC7-9267-E5FA4078FF57Q41776430-547B8CBA-EC98-4C11-892E-10B2ED085185Q42014212-4E59762A-7F5F-43DC-83F3-B594B7C38001Q42913346-6D01647F-AC8A-41D4-AFB7-20A7ACF60FF8Q44133694-5D65378F-114A-4FA5-9B54-666B16C791B8Q47243988-F93E9693-1FDB-4D33-89A7-B36D2C47C32DQ49292081-9EE50C3A-4CAE-4B93-B7BE-61170EC68705Q51733293-752BBC9B-790D-4B2C-8506-C127ED49D7CEQ53083588-AD6546B4-64B3-44B5-9FC8-24502C2A949E
P2860
Systemic anti-TNFalpha treatment restores diabetes-impaired skin repair in ob/ob mice by inactivation of macrophages.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Systemic anti-TNFalpha treatme ...... y inactivation of macrophages.
@en
type
label
Systemic anti-TNFalpha treatme ...... y inactivation of macrophages.
@en
prefLabel
Systemic anti-TNFalpha treatme ...... y inactivation of macrophages.
@en
P2093
P356
P1476
Systemic anti-TNFalpha treatme ...... by inactivation of macrophages
@en
P2093
Dana Schiefelbein
Elke Müller
Heiko Mühl
Itamar Goren
Josef Pfeilschifter
Stefan Frank
P2888
P304
P356
10.1038/SJ.JID.5700842
P407
P50
P577
2007-04-26T00:00:00Z
P5875
P6179
1050231512